Baidu
map

肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2018 ESMO/EURACAN临床实践指南：软组织和内脏肉瘤的诊断，治疗和随访

2018-05-20 欧洲肿瘤内科学会 Annals of Oncology .2018 ,(Supplement ): iv1–iv17,

软组织肉瘤内脏肉瘤

2018年5月，欧洲肿瘤内科学会(ESMO)联合EURACAN共同发布了软组织和内脏肉瘤的诊断，治疗和随访指南，指南主要内容涉及软组织和内脏肉瘤的发病率和流行病学，诊断以及病理和分子生物学诊断，肿瘤分期和风险评估，局部肿瘤管理，晚期以及转移性肿瘤的管理，随访。

中文标题：

2018 ESMO/EURACAN临床实践指南：软组织和内脏肉瘤的诊断，治疗和随访

英文标题：

Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

发布机构：

欧洲肿瘤内科学会

发布日期：

2018-05-20

简要介绍：

2018年5月，欧洲肿瘤内科学会(ESMO)联合EURACAN共同发布了软组织和内脏肉瘤的诊断，治疗和随访指南，指南主要内容涉及软组织和内脏肉瘤的发病率和流行病学，诊断以及病理和分子生物学诊断，肿瘤分期和风险评估，局部肿瘤管理，晚期以及转移性肿瘤的管理，随访。 

拓展指南：与肉瘤相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 ESMO/EURACAN临床实践指南：软组织和内脏肉瘤的诊断，治疗和随访)] GetToolGuiderByIdResponse(projectId=1, id=5377e1c0015992ad, title=2018 ESMO/EURACAN临床实践指南：软组织和内脏肉瘤的诊断，治疗和随访, enTitle=Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up, guiderFrom=Annals of Oncology .2018 ,(Supplement ): iv1–iv17,, authorId=null, author=, summary=2018年5月，欧洲肿瘤内科学会(ESMO)联合EURACAN共同发布了软组织和内脏肉瘤的诊断，治疗和随访指南，指南主要内容涉及软组织和内脏肉瘤的发病率和流行病学，诊断以及病理和分子生物学诊断，肿瘤分期和风险评估，局部肿瘤管理，晚期以及转移性肿瘤的管理，随访。 , cover=, journalId=null, articlesId=null, associationId=14, associationName=欧洲肿瘤内科学会, associationIntro=欧洲肿瘤内科学会（ESMO，European Society for Medical Oncology )是1975年成立的非盈利组织，是欧洲领先的专业组织，致力于提高肿瘤内科的专业性，推进癌症治疗和护理的多学科诊疗方法。, copyright=0, guiderPublishedTime=Sun May 20 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年5月，欧洲肿瘤内科学会(ESMO)联合EURACAN共同发布了软组织和内脏肉瘤的诊断，治疗和随访指南，指南主要内容涉及软组织和内脏肉瘤的发病率和流行病学，诊断以及病理和分子生物学诊断，肿瘤分期和风险评估，局部肿瘤管理，晚期以及转移性肿瘤的管理，随访。 </div> <div><br> </div>拓展指南：<strong>与<font color=red>肉瘤</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=35cda1c001513040" title="中国儿童及青少年横纹肌肉瘤诊疗建议(CCCG－RMS－2016)" target=_blank>中国儿童及青少年横纹肌肉瘤诊疗建议(CCCG－RMS－2016)</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=f270b1c001a05eea" title="2017 ABS共识声明：软组织肉瘤近距离放射治疗" target=_blank>2017 ABS共识声明：软组织肉瘤近距离放射治疗</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=06d451c0013e28ff" title="（2017.V1）NCCN临床实践指南：软组织肉瘤" target=_blank>（2017.V1）NCCN临床实践指南：软组织肉瘤</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=a648b1c00130086b" title="2016 NCCN临床实践指南：软组织肉瘤（2016.V2）" target=_blank>2016 NCCN临床实践指南：软组织肉瘤（2016.V2）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=5b8741c001300338" title="2017 NCCN临床实践指南：隆突性皮肤纤维肉瘤（2017.V1）" target=_blank>2017 NCCN临床实践指南：隆突性皮肤纤维肉瘤（2017.V1）</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E8%82%89%E7%98%A4" target=_blank>有关肉瘤更多指南</a></ul>, tagList=[TagDto(tagId=2794, tagName=软组织肉瘤), TagDto(tagId=75832, tagName=内脏肉瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4303, appHits=97, showAppHits=0, pcHits=3250, showPcHits=1575, likes=134, shares=3, comments=10, approvalStatus=1, publishedTime=Sun Jun 03 22:48:33 CST 2018, publishedTimeString=2018-05-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Jun 03 22:48:33 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 22:47:42 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 ESMO/EURACAN临床实践指南：软组织和内脏肉瘤的诊断，治疗和随访)])
2018 ESMO/EURACAN临床实践指南：软组织和内脏肉瘤的诊断，治疗和随访
下载请点击：
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=321602, encodeId=ced0321602e3, content=很好的学习机会, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Tue Jun 05 07:51:20 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321389, encodeId=9535321389af, content=一起学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Mon Jun 04 08:45:47 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321385, encodeId=6339321385b2, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Mon Jun 04 08:45:26 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321324, encodeId=28cb32132404, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Mon Jun 04 07:05:36 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321308, encodeId=4693321308ba, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Jun 04 06:56:56 CST 2018, time=2018-06-04, status=1, ipAttribution=)]
    2018-06-05 一天没事干

    很好的学习机会

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=321602, encodeId=ced0321602e3, content=很好的学习机会, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Tue Jun 05 07:51:20 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321389, encodeId=9535321389af, content=一起学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Mon Jun 04 08:45:47 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321385, encodeId=6339321385b2, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Mon Jun 04 08:45:26 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321324, encodeId=28cb32132404, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Mon Jun 04 07:05:36 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321308, encodeId=4693321308ba, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Jun 04 06:56:56 CST 2018, time=2018-06-04, status=1, ipAttribution=)]
    2018-06-04 wzb521zf

    一起学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=321602, encodeId=ced0321602e3, content=很好的学习机会, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Tue Jun 05 07:51:20 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321389, encodeId=9535321389af, content=一起学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Mon Jun 04 08:45:47 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321385, encodeId=6339321385b2, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Mon Jun 04 08:45:26 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321324, encodeId=28cb32132404, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Mon Jun 04 07:05:36 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321308, encodeId=4693321308ba, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Jun 04 06:56:56 CST 2018, time=2018-06-04, status=1, ipAttribution=)]
    2018-06-04 龙胆草

    学习谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=321602, encodeId=ced0321602e3, content=很好的学习机会, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Tue Jun 05 07:51:20 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321389, encodeId=9535321389af, content=一起学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Mon Jun 04 08:45:47 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321385, encodeId=6339321385b2, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Mon Jun 04 08:45:26 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321324, encodeId=28cb32132404, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Mon Jun 04 07:05:36 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321308, encodeId=4693321308ba, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Jun 04 06:56:56 CST 2018, time=2018-06-04, status=1, ipAttribution=)]
    2018-06-04 神功盖世

    阅

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=321602, encodeId=ced0321602e3, content=很好的学习机会, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Tue Jun 05 07:51:20 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321389, encodeId=9535321389af, content=一起学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Mon Jun 04 08:45:47 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321385, encodeId=6339321385b2, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Mon Jun 04 08:45:26 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321324, encodeId=28cb32132404, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Mon Jun 04 07:05:36 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=321308, encodeId=4693321308ba, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Jun 04 06:56:56 CST 2018, time=2018-06-04, status=1, ipAttribution=)]
    2018-06-04 1209e435m98(暂无昵称)

    学习了.谢谢分享

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2015 软组织肉瘤患者诊断和治疗指南

国外肿瘤科相关专家小组（统称） · 2015-11-12

Baidu
map
Baidu
map
Baidu
map